First Citizens Financial Corp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$286K Buy
1,916
+66
+4% +$9.26K 0.12% 112
2026
Q2
$234K Buy
1,850
+169
+10% +$22.3K 0.1% 126
2026
Q1
$234K Buy
+1,681
New +$235K 0.11% 125

Other funds holding GILD

First Citizens Financial Corp's GILD Position: Q3 2026 in Review

First Citizens Financial Corp increased its Gilead Sciences (GILD) stake by 3.6% in Q3 2026, buying an estimated $9.26K and bringing the position to 1,916 shares worth $286K. The position accounts for 0.12% of the portfolio, ranked #112.

First Citizens Financial Corp first reported a position in GILD in Q1 2026 and has held it in 3 quarters since. 21 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • First Citizens Financial Corp held 1,916 shares of Gilead Sciences worth $286K as of Q3 2026.
  • First Citizens Financial Corp bought 66 Gilead Sciences shares in Q3 2026, an estimated $9.26K.
  • Gilead Sciences made up 0.12% of First Citizens Financial Corp's portfolio in Q3 2026, its #112 holding.
  • First Citizens Financial Corp first reported a position in Gilead Sciences in Q1 2026 and has held it in 3 quarters since.
  • 21 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on First Citizens Financial Corp's 13F filing for Q3 2026, filed 2 Oct 2026.